DDR1 and liver cancer: In our previous study, we have found that DDR1 was significantly increased in tumor tissues of patients with early recurrence after HCC (<1 year) compared with those with non-early recurrence (> 2 years) [9], suggesting that DDR1 might be a key factor for early recurrence in patients with liver cancer.